551 related articles for article (PubMed ID: 37498232)
1. Designing a Novel Coamorphous Salt Formulation of Telmisartan with Amlodipine to Enhance Permeability and Oral Absorption.
Hatanaka Y; Uchiyama H; Kaneko S; Ueda K; Higashi K; Moribe K; Furukawa S; Takase M; Yamanaka S; Kadota K; Tozuka Y
Mol Pharm; 2023 Aug; 20(8):4071-4085. PubMed ID: 37498232
[TBL] [Abstract][Full Text] [Related]
2. The Enhanced Skin Permeation of Flavonoids Via the Application of a Coamorphous in a Microemulsion Formulation.
Uchiyama H; Hanamoto Y; Hatanaka Y; Kadota K; Tozuka Y
J Pharm Sci; 2023 Dec; 112(12):3067-3074. PubMed ID: 37364773
[TBL] [Abstract][Full Text] [Related]
3. Triple Strategies to Improve Oral Bioavailability by Fabricating Coamorphous Forms of Ursolic Acid with Piperine: Enhancing Water-Solubility, Permeability, and Inhibiting Cytochrome P450 Isozymes.
Yu D; Kan Z; Shan F; Zang J; Zhou J
Mol Pharm; 2020 Dec; 17(12):4443-4462. PubMed ID: 32926628
[TBL] [Abstract][Full Text] [Related]
4. [Construction of Coamorphous Technology Aimed at Improving Membrane Permeability and Application to Emulsion].
Uchiyama H
Yakugaku Zasshi; 2021; 141(11):1223-1228. PubMed ID: 34719541
[TBL] [Abstract][Full Text] [Related]
5. Coamorphous Loratadine-Citric Acid System with Enhanced Physical Stability and Bioavailability.
Wang J; Chang R; Zhao Y; Zhang J; Zhang T; Fu Q; Chang C; Zeng A
AAPS PharmSciTech; 2017 Oct; 18(7):2541-2550. PubMed ID: 28224393
[TBL] [Abstract][Full Text] [Related]
6. Practical Approach to Modeling the Impact of Amorphous Drug Nanoparticles on the Oral Absorption of Poorly Soluble Drugs.
Stewart AM; Grass ME
Mol Pharm; 2020 Jan; 17(1):180-189. PubMed ID: 31743032
[TBL] [Abstract][Full Text] [Related]
7. Improving the Solubility, Dissolution, and Bioavailability of Ibrutinib by Preparing It in a Coamorphous State With Saccharin.
Shi X; Song S; Ding Z; Fan B; Huang W; Xu T
J Pharm Sci; 2019 Sep; 108(9):3020-3028. PubMed ID: 31067482
[TBL] [Abstract][Full Text] [Related]
8. Understanding
B Shekhawat P; B Pokharkar V
Acta Pharm Sin B; 2017 May; 7(3):260-280. PubMed ID: 28540164
[TBL] [Abstract][Full Text] [Related]
9. Preparation and Characterization of a Rifampicin Coamorphous Material with Tromethamine Coformer: An Experimental-Theoretical Study.
Queiroz LHS; Barros RS; de Sousa FF; Lage MR; Sarraguça MC; Ribeiro PRS
Mol Pharm; 2024 Mar; 21(3):1272-1284. PubMed ID: 38361428
[TBL] [Abstract][Full Text] [Related]
10. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
[TBL] [Abstract][Full Text] [Related]
11. Coamorphous System of Florfenicol-Oxymatrine for Improving the Solubility and Dissolution Rate of Florfenicol: Preparation, Characterization and Molecular Dynamics Simulation.
Li B; Hu Y; Guo Y; Xu R; Fang X; Xiao X; Jiang C; Lu S
J Pharm Sci; 2021 Jun; 110(6):2544-2554. PubMed ID: 33577826
[TBL] [Abstract][Full Text] [Related]
12. Estimation of effective intestinal membrane permeability considering bile micelle solubilisation.
Sugano K
Int J Pharm; 2009 Feb; 368(1-2):116-22. PubMed ID: 18992315
[TBL] [Abstract][Full Text] [Related]
13. A novel drug-drug coamorphous system without molecular interactions: improve the physicochemical properties of tadalafil and repaglinide.
Su M; Xia Y; Shen Y; Heng W; Wei Y; Zhang L; Gao Y; Zhang J; Qian S
RSC Adv; 2019 Dec; 10(1):565-583. PubMed ID: 35492562
[TBL] [Abstract][Full Text] [Related]
14. Determination of the Optimal Molar Ratio in Amino Acid-Based Coamorphous Systems.
Liu J; Rades T; Grohganz H
Mol Pharm; 2020 Apr; 17(4):1335-1342. PubMed ID: 32119557
[TBL] [Abstract][Full Text] [Related]
15. Enhanced Physical Stability and Synchronized Release of Febuxostat and Indomethacin in Coamorphous Solids.
Moinuddin SM; Shi Q; Tao J; Guo M; Zhang J; Xue Q; Ruan S; Cai T
AAPS PharmSciTech; 2020 Jan; 21(2):41. PubMed ID: 31898765
[TBL] [Abstract][Full Text] [Related]
16. The solubility-permeability interplay: mechanistic modeling and predictive application of the impact of micellar solubilization on intestinal permeation.
Miller JM; Beig A; Krieg BJ; Carr RA; Borchardt TB; Amidon GE; Amidon GL; Dahan A
Mol Pharm; 2011 Oct; 8(5):1848-56. PubMed ID: 21800883
[TBL] [Abstract][Full Text] [Related]
17. Coamorphous repaglinide-saccharin with enhanced dissolution.
Gao Y; Liao J; Qi X; Zhang J
Int J Pharm; 2013 Jun; 450(1-2):290-5. PubMed ID: 23612357
[TBL] [Abstract][Full Text] [Related]
18. Injection-Molded Coamorphous Tablets: Analysis of Intermolecular Interaction and Crystallization Propensity.
Tanaka R; Ishihara S; Sasaki T; Hattori Y; Otsuka M
J Pharm Sci; 2021 Sep; 110(9):3289-3297. PubMed ID: 34147517
[TBL] [Abstract][Full Text] [Related]
19. Prediction of Liquid-Liquid Phase Separation at the Dissolving Drug Salt Particle Surface.
Uekusa T; Sugano K
Mol Pharm; 2023 Jun; 20(6):3140-3149. PubMed ID: 37183369
[TBL] [Abstract][Full Text] [Related]
20. Drug-Drug Multicomponent Solid Forms: Cocrystal, Coamorphous and Eutectic of Three Poorly Soluble Antihypertensive Drugs Using Mechanochemical Approach.
Haneef J; Chadha R
AAPS PharmSciTech; 2017 Aug; 18(6):2279-2290. PubMed ID: 28101724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]